APA (7th ed.) Citation

S, A., R, D., V, S., GD, P., SL, C., U, V., . . . CF, P. (2006). Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment. The Journal of antimicrobial chemotherapy, 58(4), 714. https://doi.org/10.1093/jac/dkl306

Chicago Style (17th ed.) Citation

S, Aquaro, et al. "Specific Mutations in HIV-1 Gp41 Are Associated with Immunological Success in HIV-1-infected Patients Receiving Enfuvirtide Treatment." The Journal of Antimicrobial Chemotherapy 58, no. 4 (2006): 714. https://doi.org/10.1093/jac/dkl306.

MLA (9th ed.) Citation

S, Aquaro, et al. "Specific Mutations in HIV-1 Gp41 Are Associated with Immunological Success in HIV-1-infected Patients Receiving Enfuvirtide Treatment." The Journal of Antimicrobial Chemotherapy, vol. 58, no. 4, 2006, p. 714, https://doi.org/10.1093/jac/dkl306.